Hospital
Hospital Service District #2 of Lasalle Parish
Hospital Service District #2 of Lasalle Parish was paid $3.63M by Medicaid between Jan 2018 and Dec 2024, across 89 billing codes. Its largest line is 99285, emergency room visit (most serious) — 38% of everything it billed.
33Billing provider infoHOSPITAL SERVICE DISTRICT #2 OF LASALLE PARISH
JENA, LA 71342
JENA, LA 71342
33aNPI1801825005assigned 07/01/2006
33bProvider typePsychiatric Hospital Unit
28Total paid$3.63M
24GClaims143,951
24DCodes billed89
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Psychiatric Hospital Unit providers in Louisiana
Rank by total paid#4 of 7
Median peer was paid$3.63M
This provider vs. median1.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 17,397 | $351K | |
| 2019 | 22,201 | $406K | |
| 2020 | 16,010 | $308K | |
| 2021 | 22,445 | $518K | |
| 2022 | 26,993 | $728K | |
| 2023 | 26,527 | $838K | |
| 2024incomplete | 12,378 | $478K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 38% | 6,373 | 5,350 | $1.36M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 22% | 9,574 | 8,381 | $792K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 3.7% | 5,073 | 1,259 | $134K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 3.3% | 3,653 | 3,115 | $121K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 3.2% | 6,677 | 1,455 | $117K |
| 71046 | Radiologic examination, chest; 2 views | 2.6% | 1,752 | 1,500 | $96K |
| A0425 | Ground mileage, per statute mile | 2.5% | 1,837 | 1,322 | $92K |
| G0378 | Hospital observation service, per hour | 2.4% | 222 | 63 | $88K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 1.5% | 453 | 396 | $55K |
| 87276 | 1.5% | 4,120 | 3,682 | $53K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 1.4% | 3,781 | 773 | $51K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.4% | 1,080 | 874 | $51K |
77 more codes
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.3% | 1,847 | $48K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.3% | 10,716 | $48K |
| 80053 | Comprehensive metabolic panel | 1.3% | 8,489 | $47K |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | 1.2% | 20,037 | $44K |
| J7030 | Infusion, normal saline solution , 1000 cc | 1.2% | 1,478 | $43K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.2% | 2,405 | $42K |
| 87275 | 1.2% | 4,124 | $42K | |
| 36415 | Collection of venous blood by venipuncture | 1.0% | 20,120 | $38K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 2,109 | $27K |
| 97161 | <1% | 592 | $21K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 651 | $18K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 457 | $16K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 111 | $15K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 732 | $10K |
| A0427 | Emergency ambulance ride, advanced life support | <1% | 910 | $10K |
| 84484 | <1% | 1,639 | $9K | |
| 80050 | General health panel | <1% | 264 | $9K |
| 71045 | Radiologic examination, chest; single view | <1% | 394 | $8K |
| 82553 | <1% | 1,715 | $8K | |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | <1% | 68 | $8K |
| 87420 | <1% | 634 | $8K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 2,637 | $6K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 632 | $6K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 116 | $6K |
| 81001 | <1% | 3,208 | $6K | |
| 82550 | <1% | 1,861 | $6K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 261 | $5K |
| A0428 | Ambulance service, basic life support, non-emergency transport, (bls) | <1% | 70 | $5K |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 37 | $5K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 955 | $4K |
| 80306 | <1% | 359 | $4K | |
| J3490 | Unclassified drugs | <1% | 853 | $3K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 56 | $3K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 388 | $3K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 135 | $3K |
| 84703 | <1% | 483 | $3K | |
| 87486 | <1% | 92 | $3K | |
| 87581 | <1% | 92 | $3K | |
| 80061 | Lipid panel | <1% | 238 | $2K |
| A4216 | Sterile water, saline and/or dextrose, diluent/flush, 10 ml | <1% | 1,867 | $2K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 106 | $2K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 485 | $2K |
| 92523 | <1% | 15 | $2K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 16 | $2K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 331 | $1K |
| 85027 | <1% | 334 | $1K | |
| J7131 | Hypertonic saline solution, 1 ml | <1% | 974 | $866.94 |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 64 | $836.23 |
| 81003 | <1% | 589 | $820.29 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 109 | $772.77 |
| 86357 | <1% | 16 | $603.68 | |
| 86355 | <1% | 16 | $603.68 | |
| 87498 | <1% | 16 | $561.44 | |
| 87496 | <1% | 16 | $561.44 | |
| 87532 | <1% | 16 | $561.44 | |
| 85379 | <1% | 92 | $549.75 | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 159 | $498.40 |
| 87040 | <1% | 55 | $491.69 | |
| 86140 | <1% | 146 | $463.06 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 89 | $455.29 |
| 87503 | <1% | 16 | $452.16 | |
| 83690 | <1% | 70 | $348.56 | |
| 83655 | <1% | 27 | $326.97 | |
| 83735 | <1% | 75 | $303.16 | |
| 85610 | <1% | 116 | $271.78 | |
| 83605 | <1% | 45 | $256.99 | |
| 82077 | <1% | 33 | $256.43 | |
| 82150 | <1% | 55 | $229.15 | |
| 85730 | <1% | 68 | $189.16 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 15 | $120.54 |
| 85651 | <1% | 12 | $42.70 | |
| 85018 | <1% | 18 | $42.66 | |
| 84436 | <1% | 15 | $19.74 | |
| A9270 | Non-covered item or service | 0% | 58 | $0.00 |
| 99214 | Doctor's office visit, returning patient (more involved) | 0% | 246 | $0.00 |
| T1015 | A visit at a community health center or clinic (one all-in rate) | 0% | 901 | $0.00 |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 0% | 110 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialFRANCIS, LANA (CHIEF EXECUTIVE OFFICER)
| Provider | Location | Paid |
|---|---|---|
| Hospital Service District #2 of Lasalle Parish | Jena, LA | $8.25M |
| Hospital Service District #2 of Lasalle Parish | Jena, LA | $989K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.